Vaxart
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $4,933 | $6,401 | $2,181 | $3,245 |
Gross Profit | 4,933 | -11,079 | 1,081 | 2,045 |
EBITDA | -12,331 | -14,043 | -21,893 | -15,127 |
EBIT | -14,555 | -16,256 | -22,993 | -16,327 |
Net Income | -14,080 | -16,466 | -24,417 | -17,375 |
Net Change In Cash | 4,933 | 6,401 | 2,181 | 3,245 |
Free Cash Flow | -4,210 | -12,397 | -21,322 | -13,417 |
Cash | 22,035 | 43,285 | 26,735 | 34,755 |
Basic Shares | 227,452 | 184,703 | 168,811 | 153,452 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,379 | $107 | $892 | $4,046 |
Gross Profit | -60,763 | -3,160 | -47,857 | -15,817 |
EBITDA | -74,723 | -103,119 | -66,451 | -28,262 |
EBIT | -83,347 | -106,386 | -68,883 | -30,108 |
Net Income | -82,465 | -107,758 | -70,470 | -32,220 |
Net Change In Cash | 7,379 | 107 | 892 | 4,046 |
Cost of Revenue | -97,732 | 16,875 | 113,344 | |
Free Cash Flow | -72,324 | -104,380 | -64,989 | -24,973 |
Cash | 34,755 | 44,013 | 143,745 | 126,870 |
Basic Shares | 144,819 | 127,683 | 121,453 | 88,295 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.06 |
2024-06-30 | -$0.09 |
2024-03-31 | -$0.14 |
2023-12-31 | -$0.12 |
